N/A Completed N=57 Other

Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study

Source: ClinicalTrials.gov NCT01706705 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2022

Primary outcomePrimary: Number of Participants With Improved Image Quality in the Shifted Position — 0; 15 Participants

Summary

The goal of this clinical research study is to learn if computed tomography (CT) and magnetic resonance imaging (MRI) images can better help to plan internal radiation treatment.

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants With Improved Image Quality in the Shifted Position	0; 15	—
SECONDARY Number of Participants With High Quality Images With the Adaptive Applicator in the Shifted or Standard Position	0; 15	—

Eligibility Criteria

Inclusion Criteria

Women with stage greater than or equal to IB2 cervical cancer treated with definitive chemoradiation or radiation therapy who require intracavitary brachytherapy.

Exclusion Criteria

Patient or tumor anatomy that requires use of a non-MRI-compatible applicator.
Patients who require interstitial brachytherapy.
Patients whose treating physician feels that they require additional 3D imaging at the time of implant based on physical exam or initial findings.
Patients with implantable cardioverter-defibrillator, pacemaker or other implanted device, which precludes MRI acquisition.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01706705). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.